<SEC-DOCUMENT>0000950159-19-000031.txt : 20190226
<SEC-HEADER>0000950159-19-000031.hdr.sgml : 20190226
<ACCEPTANCE-DATETIME>20190226060047
ACCESSION NUMBER:		0000950159-19-000031
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190226
ITEM INFORMATION:		Regulation FD Disclosure
FILED AS OF DATE:		20190226
DATE AS OF CHANGE:		20190226

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cigna Corp
		CENTRAL INDEX KEY:			0001739940
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				824991898
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38769
		FILM NUMBER:		19631510

	BUSINESS ADDRESS:	
		STREET 1:		900 COTTAGE GROVE ROAD
		CITY:			BLOOMFIELD
		STATE:			CT
		ZIP:			06002
		BUSINESS PHONE:		8602266000

	MAIL ADDRESS:	
		STREET 1:		900 COTTAGE GROVE ROAD
		CITY:			BLOOMFIELD
		STATE:			CT
		ZIP:			06002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Halfmoon Parent, Inc.
		DATE OF NAME CHANGE:	20180508
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cigna8k.htm
<DESCRIPTION>CIGNA CORPORATION FORM 8-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: The Scullin Group
         Document created using EDGARfilings PROfile 5.0.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body text="#000000" bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
  <div><br>
  </div>
  <div><br>
  </div>
  <div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">SECURITIES AND EXCHANGE COMMISSION</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Washington, D.C. 20549</font></div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">FORM 8&#8209;K</font></div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">CURRENT REPORT</font></div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Pursuant to Section 13 or 15(d) of the</font></div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Securities Exchange Act of 1934</font></div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Date of Report (Date of earliest event reported) <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight:
            bold;">February 26, 2019</font></font></div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Cigna Corporation</font></div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</font>(Exact name of registrant as
          specified in its charter)</font></div>
    </div>
    <div>
      <div><br>
      </div>
      <div><br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z63c7d3f2a45e4256a2deb93207520d4f" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;">

        <tr>
          <td style="width: 31.26%; vertical-align: top;">
            <div>
              <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Delaware</font></div>
              <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(State or other jurisdiction of incorporation)</font></div>
            </div>
          </td>
          <td style="width: 34.37%; vertical-align: top;">
            <div>
              <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;"><font style="background-color: #FFFFFF; font-size: 10pt; font-family: 'Times New Roman', Times,
                    serif;">001-38769</font></font></div>
              <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(Commission File Number)</font></div>
            </div>
          </td>
          <td style="width: 34.37%; vertical-align: top;">
            <div>
              <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;"><font style="background-color: #FFFFFF; font-size: 10pt; font-family: 'Times New Roman', Times,
                    serif;">82-4991898</font></font></div>
              <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</font>(IRS Employer</font></div>
              <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Identification No.)</font></div>
            </div>
          </td>
        </tr>

    </table>
    <div>
      <div><br>
      </div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">900 Cottage Grove Road</font></div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Bloomfield, Connecticut 06002</font></div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(Address of principal executive offices)&#160; (Zip Code)</font></div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Registrant&#8217;s telephone number, including area code:</font></div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">(860) 226&#8209;6000</font></div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Not Applicable</font></div>
      <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(Former name or former address, if changed since last report)</font></div>
    </div>
    <div>
      <div><br>
      </div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any
          of the following provisions:</font></div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">[ ]&#160; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>
    </div>
    <div>
      <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">[ ]&#160; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
          240.14d-2(b))</font></div>
      <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">[ ]&#160; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
          240.13e-4(c))</font></div>
      <div><br>
      </div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
          &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</font></div>
      <div><br>
      </div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Emerging growth company <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#9744;</font></font></div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
          with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#9744;</font></font></div>
    </div>
    <div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> </font><br>
      </div>
      <div>&#160;</div>
      <div><br>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Item 7.01</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Regulation
        FD Disclosure.</font></div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">Cigna Corporation (&#8220;Cigna&#8221;) officials expect to
          participate in meetings with investors and analysts over the next several weeks.&#160; During these meetings, Cigna officials expect to </font>reaffirm projected full year 2019 consolidated adjusted income from operations, which remains in the range
        of $6.2 billion to $6.4 billion.</font></div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Cigna discussed its full year 2019 outlook in its press release dated February 1, 2019 and during the related investor conference call.&#160; The
        press release and the conference call transcript are available under Quarterly Reports and SEC Filings in the Investor Relations section of the Company&#8217;s website located at www.cigna.com/aboutcigna/investors.</font></div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Adjusted income (loss) from operations is defined as shareholders&#8217; net income (loss) excluding the following adjustments:&#160; net realized
        investment results, amortization of acquired intangible assets, special items, and earnings contributions from transitioning pharmacy benefit management clients, Anthem Inc. and Coventry Health Care, Inc.&#160; Adjusted income (loss) from operations is
        measured on an after-tax basis for consolidated results.&#160; Adjusted income (loss) from operations is a measure of profitability used by Cigna&#8217;s management because it presents the underlying results of operations of Cigna&#8217;s businesses and permits
        analysis of trends in underlying revenue, expenses and shareholders&#8217; net income.&#160; This consolidated measure is not determined in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and should not be
        viewed as a substitute for the most directly comparable GAAP measure, shareholders&#8217; net income.&#160; Management is not able to provide a reconciliation to shareholders&#8217; net income (loss) on a forward-looking basis because we are unable to predict,
        without unreasonable effort, certain components thereof including (i) future net realized investment results and (ii) future special items. These items are inherently uncertain and depend on various factors, many of which are beyond our control. As
        such, any associated estimate and its impact on shareholders&#8217; net income could vary materially.</font></div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">This information shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;),
        or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act whether made before or after the date of this report, except as shall be expressly set forth by specific reference in such a filing.</font></div>
    <div>&#160;</div>
    <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; color: #000000;">CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM
        ACT OF 1995</font></div>
    <div>&#160;</div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">This Current Report on Form 8-K (the &#8220;Report&#8221;), and oral statements made with respect to information contained in this Report, may contain
        forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.&#160; Forward-looking statements are based on Cigna's current expectations and projections about future trends, events and uncertainties.&#160; These
        statements are not historical facts.&#160; Forward-looking statements may include, among others, statements relating to our projected full year 2019 consolidated adjusted income from operations as reflected in Item 7.01 of this Report, as well as
        statements made in our press release dated February 1, 2019 and related investor conference call concerning our projected adjusted income (loss) from operations outlook for 2019, on both a consolidated and segment basis; projected adjusted revenue
        outlook for 2019; projected global medical customer growth over year end 2018; projected growth beyond 2019; statements concerning our long-term projected adjusted income (loss) from operations outlook; projected medical care and SG&amp;A expense
        ratios and medical cost trends; projected adjusted pharmacy claims; our projected consolidated adjusted tax rate; future financial or operating performance, including our ability to deliver personalized and innovative solutions for our customers
        and clients; future growth, business strategy, strategic or operational initiatives; economic, regulatory or competitive environments, particularly with respect to the pace and extent of change in these areas; financing or capital deployment plans
        and amounts available for future deployment; our prospects for growth in the coming years; the merger (the &#8220;Merger&#8221;) with Express Scripts Holding Company (&#8220;Express Scripts&#8221;) and other statements regarding Cigna's future beliefs, expectations,
        plans, intentions, financial condition or performance. You may identify forward-looking statements by the use of words such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will&#8221; or other
        words or expressions of similar meaning, although not all forward-looking statements contain such terms.</font></div>
    <div>&#160;</div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div> <br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Forward-looking statements are subject to risks and uncertainties, both known and unknown, that could cause actual results to differ materially
        from those expressed or implied in forward-looking statements. Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage
        medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic
        acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or
        changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and/or guaranty fund assessments; uncertainties surrounding participation in government-sponsored programs such as Medicare; the
        effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; the
        possibility that the anticipated benefits (including anticipated synergies) from the Merger cannot be realized in full, or at all or may take longer to realize than expected; problems regarding the successful integration of the businesses of
        Express Scripts and Cigna; unexpected costs regarding the Merger; the ability to retain key personnel; as well as more specific risks and uncertainties discussed in our most recent report on Form 10-K and subsequent reports on Forms 10-Q and 8-K
        available on the Investor Relations section of www.cigna.com as well as on Express Scripts&#8217; most recent report on Form 10-K and subsequent reports on Forms 10-Q and 8-K available on the Investor Relations section of www.express-scripts.com. You
        should not place undue reliance on forward-looking statements, which speak only as of the date they are made, are not guarantees of future performance or results, and are subject to risks, uncertainties and assumptions that are difficult to predict
        or quantify. Cigna undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by law.</font></div>
    <div>&#160;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div style="text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">SIGNATURE</font></div>
    <div><br>
    </div>
    <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
        the undersigned hereunto duly authorized.</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z8eef572aec264839bd110b6697c309b1" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse;">

        <tr>
          <td style="width: 56.21%; vertical-align: top;">&#160;</td>
          <td style="width: 43.79%; vertical-align: top;" colspan="2">
            <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Cigna Corporation</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 56.21%; vertical-align: top;">&#160;</td>
          <td style="width: 9.6%; vertical-align: top;">&#160;</td>
          <td style="width: 34.19%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 56.21%; vertical-align: top;">&#160;</td>
          <td style="width: 9.6%; vertical-align: top;">&#160;</td>
          <td style="width: 34.19%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 56.21%; vertical-align: top;">
            <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Date:&#160; February 26, 2019</font></div>
          </td>
          <td style="width: 9.6%; vertical-align: top;">
            <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">By:</font></div>
          </td>
          <td style="width: 34.19%; vertical-align: top; border-bottom: 2px solid black;">
            <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">/s/ Eric P. Palmer</font></font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 56.21%; vertical-align: top;">&#160;</td>
          <td style="width: 9.6%; vertical-align: top;">&#160;</td>
          <td style="width: 34.19%; vertical-align: top;">
            <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Eric P. Palmer</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 56.21%; vertical-align: top;">&#160;</td>
          <td style="width: 9.6%; vertical-align: top;">&#160;</td>
          <td style="width: 34.19%; vertical-align: top;">
            <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Executive Vice President and</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 56.21%; vertical-align: top;">&#160;</td>
          <td style="width: 9.6%; vertical-align: top;">&#160;</td>
          <td style="width: 34.19%; vertical-align: top;">
            <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Chief Financial Officer</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>&#160;</div>
    <div><br>
    </div>
    <div>&#160;</div>
    <div><br>
    </div>
    <div>&#160;</div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
